Detailed information for compound 522376

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 558.089 | Formula: C28H32ClN3O5S
  • H donors: 0 H acceptors: 5 LogP: 3.96 Rotable bonds: 12
    Rule of 5 violations (Lipinski): 2
  • SMILES: CCOC(=O)CCN(C(=O)CCS(=O)(=O)c1ccc2c(c1)ccc(c2)Cl)C1CCN(CC1)c1ccncc1
  • InChi: 1S/C28H32ClN3O5S/c1-2-37-28(34)11-17-32(25-9-15-31(16-10-25)24-7-13-30-14-8-24)27(33)12-18-38(35,36)26-6-4-21-19-23(29)5-3-22(21)20-26/h3-8,13-14,19-20,25H,2,9-12,15-18H2,1H3
  • InChiKey: BPMZBEJQLCBOPO-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens coagulation factor X Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus granulosus choline:ethanolamine kinase 0.0041 0.941 0.941
Echinococcus granulosus carboxylesterase 5A 0.0042 1 1
Echinococcus granulosus acetylcholinesterase 0.0042 1 1
Plasmodium falciparum choline kinase 0.0041 0.941 0.5
Echinococcus multilocularis acetylcholinesterase 0.0042 1 1
Loa Loa (eye worm) carboxylesterase 0.0042 1 1
Echinococcus granulosus acetylcholinesterase 0.0042 1 1
Brugia malayi Choline/ethanolamine kinase family protein 0.0041 0.941 0.941
Toxoplasma gondii phosphotransferase enzyme family protein 0.0041 0.941 1
Echinococcus multilocularis carboxylesterase 5A 0.0042 1 1
Brugia malayi Carboxylesterase family protein 0.0042 1 1
Loa Loa (eye worm) acetylcholinesterase 1 0.0042 1 1
Plasmodium vivax choline kinase, putative 0.0041 0.941 0.5
Loa Loa (eye worm) hypothetical protein 0.0042 1 1
Loa Loa (eye worm) hypothetical protein 0.0042 1 1
Onchocerca volvulus Arrow homolog 0.0016 0 0.5
Echinococcus multilocularis choline:ethanolamine kinase 0.0041 0.941 0.941
Loa Loa (eye worm) choline/ethanolamine kinase 0.0041 0.941 0.941
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0042 1 1
Echinococcus multilocularis acetylcholinesterase 0.0042 1 1

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) = 0.85 uM Anticoagulant potency in human plasma assessed as concentration required to double prothrombin time after 4 mins ChEMBL. 18077174
Activity (functional) = 14 uM Anticoagulant potency in mouse plasma assessed as concentration required to double prothrombin time after 4 mins ChEMBL. 18077174
Activity (functional) = 14 uM Anticoagulant potency in mouse plasma assessed as concentration required to double prothrombin time after 4 mins ChEMBL. 18077174
IC50 (binding) = 0.037 uM Inhibition of human factor 10a ChEMBL. 18077174
IC50 (binding) = 0.037 uM Inhibition of human factor 10a ChEMBL. 18077174
Ratio (functional) = 1 Ex vivo anticoagulant potency in ICR mouse blood at 30 mg/kg, po after 1 hr expressed as ratio of prothrombin time in drug treated animal to control ChEMBL. 18077174

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.